Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs >

BioTime, Inc. (BTX)

BTX RSS Feed
Add BTX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator
Search This Board:
Last Post: 8/22/2014 11:25:54 PM - Followers: 62 - Board type: Free - Posts Today: 0

 

BioTime, Inc.  (BTX)

 

 
 

 

http://www.biotimeinc.com/

 

 

 

Company Information:

BioTime, Inc.
1301 Harbor Bay Parkway
Alameda, CA 94502

Phone: 510-521-3390
      Fax: 510-521-3389

 

CIK

0000876343

 

 

BioTime, Inc. (NYSE AMEX: BTX) is a biotechnology company engaged in two areas of biomedical research and product development:

  • Stem cell technology and products for use in regenerative medicine.  These products and technologies are being developed and marketed by our wholly owned subsidiary Embryome Sciences, Inc.
  • Blood plasma volume expanders and related technology for use in surgery, emergency trauma treatment and other applications.  Our lead product is Hextend® which is being marketed by Hospira, Inc. and CJ CheilJedang Corp. under exclusive licenses from us

 

The Potential of Regenerative Medicine

Regenerative medicine refers to therapies based on human embryonic stem ("hES") cell technology that are designed to rebuild cell and tissue function lost due to degenerative disease or injury. The great scientific and public interest in regenerative medicine lies in the potential of hES cells to transform into any cell type of the human body. hES cells therefore show considerable potential as a source of new therapies for a host of currently-incurable diseases such as: diabetes, stroke, Alzheimer's and Parkinson's disease, heart failure, arthritis, muscular dystrophy, spinal cord injury, macular degeneration, hearing loss, kidney and liver failure, as well as many other disorders that may be treated by replacing diseased or damaged organ tissues. In response to the unusual potential of the field, the State of California has allocated $3 billion over the next 10 years to fund basic research, and President Obama has lifted previous restrictions for federal funding of stem cell research.

Led by Dr. Michael West, considered by many to be a founding father of the stem cell industry, BioTime has assembled an array of products and associated intellectual property that give it the potential to be a leader in this exciting new field of medicine.

We are implementing a near-term revenues strategy in the regenerative medicine field by seeking to develop and market advanced hES products and technology that can be used by researchers at universities and biopharmaceutical companies. These research-only products generally can be marketed without regulatory (FDA) approval, and are therefore relatively near-term business opportunities when compared to human therapeutic products. We may also initiate development programs for human therapeutic applications if sufficient capital becomes available to us or through joint efforts with industry partners.

BioTime is leveraging its product development strategy on two key technology platforms:
 

  • • An advanced iPS technology allowing the transformation of human cells of the body back to a primordial stem cell state equivalent to embryonic stem cells. Using this technology with patient specific stem cells, rather than stem cells derived from embryos donated by unrelated people, may reduce the incidence of rejection of tissue grafts.
     
  • ACTCellerate™ technology that permits the generation of scalable and highly purified cells of the human body.

See this link for more information:  http://www.biotimeinc.com/aboutBT.htm

 

 

 

 

 

 

Management: 

http://www.biotimeinc.com/management.htm
 

 

Dr. Michael West, CEO

Dr. West is the Chief Executive Officer of BioTime, Inc. (NYSE AMEX: BTIM) and Embryome Sciences, Inc. of Alameda, California. The Companies are focused on developing an array of research and therapeutic products using human embryonic stem cell technology. He received his Ph.D. from Baylor College of Medicine in 1989 concentrating on the biology of cellular aging. He has focused his academic and business career on the application of developmental biology to the age-related degenerative disease. He was the Founder of Geron Corporation of Menlo Park, California (Nasdaq: GERN) and from 1990 to 1998 he was a Director, and Vice President, where he initiated and managed programs in telomerase diagnostics, oligonucleotide-based telomerase inhibition as anti-tumor therapy, and the cloning and use of telomerase in telomerase-mediated therapy wherein telomerase is utilized to immortalize human cells. From 1995 to 1998 he organized and managed the research collaboration between Geron and its academic collaborators James Thomson and John Gearhart that led to the first isolation of human embryonic stem and human embryonic germ cells. From 1998 to 2007 he was President and Chief Scientific Officer at Advanced Cell Technology, Inc. (OTCBB: ACTC) where he managed programs in animal cloning, human somatic cell nuclear transfer, retinal differentiation, and ACTCellerate, a technology for the multiplex derivation and characterization of clonal human embryonic progenitor cell lines. 

Dr. West's complete CV and background on his research interests are available online at: http://www.michaelwest.org/


 

 

 

 

Recent News: 

http://www.b2i.us/profiles/investor/ResLibrary2.asp?BzID=1152&GoTopage=&Category=1802&t=
 

 

http://finance.yahoo.com/q/h?s=BTX+Headlines

 

Subsidiaries
http://www.biotimeinc.com/subsidiaries/


 

 

Filings:

http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0000876343&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

 

 

Transfer Agent:

American Stock Transfer & Trust Company
59 Maiden Lane
New York 10038

 

Investor Relations:

Judith Segall

VP of Administration, Corporate Secretary

isegall@biotimemail.com

Phone:  510.521.3390 ext 301

 

 

 


 

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

Also, keep in mind that moderators may or may not have a position in said stock.   Being a moderator isn't a sign of endorsement.

  

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:
http://investorshub.advfn.com/boards/complex_terms.asp

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BTX
Current Price
Volume:
Bid Ask Day's Range
Wiki
BTX News: Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 08/21/2014 07:00:00 AM
BTX News: Current Report Filing (8-k) 08/12/2014 09:01:06 AM
BTX News: Current Report Filing (8-k) 08/12/2014 07:59:54 AM
BTX News: Quarterly Report (10-q) 08/11/2014 05:02:13 PM
BTX News: Current Report Filing (8-k) 07/31/2014 09:01:29 AM
PostSubject
#397   Agreed. Looking forward to hearing what they are tradetrak 08/22/14 11:25:53 PM
#396   Asty will behave like a Classic spinoff stock Adi2 08/22/14 12:00:39 AM
#395   I got some ASTY shares from the GERN tradetrak 08/21/14 09:58:27 PM
#394   Quietly, doing all the right things. New product Adi2 08/21/14 01:38:26 PM
#393   PREMVIA, MAJOR BREAKTHROUGH! envirogym 08/13/14 05:33:00 PM
#392   Somebody likes the 8-k, this will sneak up poonch1ne 08/12/14 01:13:04 PM
#391   Asterias is to be listed "This summer". At Adi2 07/04/14 09:25:29 AM
#390   "BTX" IS READY TO BREAK OUT! envirogym 06/19/14 12:46:02 PM
#389   STEM CELL TECHNOLOGY IS THE FUTURE! envirogym 06/17/14 12:01:27 PM
#387   Also pat cox replacement got spooked on a Dynarod 06/15/14 05:25:53 AM
#386   CHECK OUT THE NEW TALENT COMING INTO THE COMPANY! envirogym 06/12/14 07:04:47 PM
#385   Tom, The way I see and use Adi2 06/12/14 05:04:28 PM
#384   well, yes it seemed to be a promo 123tom 06/11/14 05:45:20 PM
#383   I TO DID NOT UNDERSTAND WHERE PATRICK WAS envirogym 06/11/14 04:47:19 PM
#382   I would be happy for BTX to be 123tom 06/11/14 04:16:46 PM
#381   Life is returning to this star! envirogym 06/11/14 11:57:38 AM
#380   Glad to see your still around 123tom, envirogym 06/11/14 11:53:53 AM
#379   Here's Patrick's latest. I just got it via george h 06/07/14 12:51:03 PM
#378   Anybody else see a bottom in the low poonch1ne 05/27/14 10:36:11 AM
#377   I miss Patrick and the newsletter.The new guy 123tom 05/27/14 01:21:49 AM
#376   Any serious investor should Listen to all of Adi2 05/22/14 11:13:36 PM
#375   I am totally on board with you. Peacefulwendy 05/18/14 06:23:52 PM
#374   BTX is a development stage company. Check insiders Adi2 05/18/14 03:02:43 PM
#373   I agree with you. I think you A Dinosaur 05/17/14 08:19:08 PM
#372   Thank you! BTX, ISCO & CUR are Peacefulwendy 05/17/14 05:06:30 PM
#371   Forgot another great Cox reco up alot is CUR poonch1ne 05/17/14 03:58:52 PM
#370   What Tom fails to mention is BTX went poonch1ne 05/17/14 03:56:18 PM
#369   Hi,Wendy, welcome to the empty room. here you will 123tom 05/16/14 06:40:40 PM
#368   I have been doing some DD on BTX Peacefulwendy 05/16/14 05:01:39 PM
#367   Wow hard to believe I was the last 123tom 05/16/14 03:27:26 AM
#366   typical Cramer pick. He said buy last week wapsi 04/08/14 08:56:19 AM
#365   ... and now its fallen to 123tom 04/03/14 07:47:49 PM
#364   BTX, WILLLLLL OVERCOME, U GO BTX$$$$$$$$$$ envirogym 03/21/14 04:16:31 PM
#363   Oooopppps...3.40 now 123tom 03/19/14 04:28:35 AM
#362   See BTX at support 3.65-3.70...and ... Ooops 123tom 03/17/14 05:35:10 PM
#361   Good luck to you too, E 123tom 03/17/14 01:45:57 AM
#360   SOLONG 123TOM, AND GOOD LUCK! envirogym 03/14/14 07:53:59 PM
#359   BTX, failed to hit 4 dollars...I'm so 123tom 03/14/14 02:44:54 PM
#358   123TOM, THOUGHTS ON CURRENT DEVELOPMENTS? envirogym 03/10/14 09:06:09 PM
#357   Next news, BREAKOUT BIGGGGGGGGGGGGG! envirogym 03/02/14 09:15:04 PM
#356   ESTABLISHING GOOD BASE HERE, ON THE MOVE! envirogym 02/26/14 10:56:54 AM
#355   HANG ON FLIPPERS, GOING UP! envirogym 02/23/14 08:51:26 PM
#354   THIS IS A TOUGH ONE, FLIPPERS MAKING THEIR PENNIES! envirogym 02/14/14 11:13:20 PM
#353   BTX holding current support 3.30 zone 123tom 02/13/14 08:10:43 PM
#352   I don't follow it daily, but, always come KarinCA 02/12/14 01:41:19 AM
#351   BUY THE WAY, WHERE ARE YOU SUPPERTROUPER? envirogym 02/11/14 02:10:33 PM
#350   JUST THE THREE OF US, ROCK AND ROLL! envirogym 02/11/14 02:06:39 PM
#349   might as well update this.... 123tom 02/09/14 01:46:00 AM
#348   BTX failed again at 3.50 support, next down 123tom 02/04/14 02:36:23 PM
#347   Unless some more good news comes out. envirogym 02/03/14 09:15:04 PM
PostSubject